Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy
Background Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC prog...
Hlavní autoři: | Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2014
|
Podobné jednotky
-
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Autor: Rajan, P, a další
Vydáno: (2014) -
Sequencing depth and coverage: key considerations in genomic analyses.
Autor: Sims, D, a další
Vydáno: (2014) -
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Autor: Shtutman Michael, a další
Vydáno: (2010-04-01) -
The early effects of rapid androgen deprivation on human prostate cancer
Autor: Shaw, G, a další
Vydáno: (2015) -
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
Autor: Justin H. Hwang, a další
Vydáno: (2019-11-01)